The ADHD Landscape – Why are all stimulants not the same (Clinical lunch chat – On Demand)
In this Clinical Lunch Chats episode, Dr Rust Theron is joined by a Psychiatrist, Professor Renata
Schoeman to explore the current ADHD treatment landscape, with a particular focus on why
stimulant medications differ and how these differences impact clinical decision-making in primary
care.
Learning Outcomes
You will learn how to:
- Describe the current understanding of ADHD across the lifespan, including its clinical presentation in children and adults.
- Differentiate between stimulant medication classes and formulations, including short-acting and long-acting preparations.
- Explain how pharmacokinetic differences influence clinical outcomes, including onset, duration, and adherence.
- Identify patient-specific factors that guide stimulant selection, including comorbidities and lifestyle considerations.
- Apply practical approaches to initiating, titrating, and monitoring stimulant therapy in
primary care.
ATTENTIONKindly note that if you attended the live webinar, you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record 1 CPD point from the live webinar, invalidating any additional CPD points from the report.Please note deNovo Medica ensures uploading of your CPD points to the HPCSA: please don't upload these yourself.
To access this module, please register or login: